Stock Spotlight: Treasury Wine Estates Limited (ASX:TWE)

This week's Stock Spotlight is ASX-listed Treasury Wine Estates Limited.


About Treasury Wine Estates Limited.


Treasury Wine Estates Limited operates as a wine company primarily in Australia, the United States, the United Kingdom, and internationally. The company engages in the viticulture and winemaking; and marketing, sale, and distribution of wine. Its wine portfolio includes luxury, premium and commercial wine brands, such as Penfolds, DAOU Vineyards, Wolf Blass, 19 Crimes, St Hubert's The Stag, Lindeman's, Squealing pig, Blossom Hill, Frank Family Vineyards, Pepperjack, Wynns, Matua, Seppelt, Beringer, Etude, Sterling Vineyards, Beaulieu Vineyard, Stags' Leap, Beringer Bros, and Castello di Gabbiano. The company also provides contract bottling services to third parties; and sells grape and bulk wine. It owns and leases vineyards in Australia and New Zealand, California, France, and Italy. The company markets and sells its products to distributors, wholesalers, retails chains, independent retailers, and on-premise outlets, as well as directly to consumers. The company was founded in 1843 and is headquartered in Melbourne, Australia.


Source: Yahoo Finance



Key Stats

Source: Yahoo Finance. Data as of 08/09/25.


Price Performance

Growth Potential

  • Trading below our revised valuation. TWE’s share price has been very weak (absolute & relative) over the past 12 months.
  • China’s removal of tariffs on Australian wine should be a positive over the medium-term.
  • Significant opportunity to grow its Asian business which will provide a more balanced exposure to the region rather than one specific country.
  • Group margin surprise on the upside due to premiumization & good cost control.
  • The turnaround in Americas business could lead to significantly higher margins.
  • Favorable currency movements (leveraged to a falling AUD/USD).
  • Capital management – TWE currently has a $200m on-market buyback.

Key Risks


  • Recovery in China disappoints relative to expectations.
  • New CEO revises earnings guidance for the key Penfolds business.
  • Slowdown in wine consumption in key markets (including structural changing to consumption).
  • Adverse movement in global wine supply and demand.
  • Increase competition in key markets or moderating pricing power.
  • Unfavorable currency movements (negative translation effect).

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

RBA’s Fifth Rate Hike of 2026: Reading the ASX Signals

November 4, 2026
The RBA lifted the cash rate to 4.85% in a split vote. Here’s how higher rates flow through ASX sectors, company earnings, dividends and valuations.

Inside Anthropic’s IPO Filing: Rapid Growth, Rising Stakes

October 29, 2026
Inside Anthropic’s IPO filing: explore its soaring revenue, computing commitments, reported losses and governance structure, and what the disclosures mean for investors.

How to Read Big Tech Earnings: What to Look for Beyond Revenue Growth

October 21, 2026
Big Tech reports next week. Learn how to read earnings releases and filings, and what to look for in AI spending, cloud growth, cash flow and guidance.

Is the AI Boom Becoming a Financial Stability Risk?

October 14, 2026
Understand how AI investment could affect global financial stability, as the IMF and RBA warn of rising debt, market concentration and funding risks.

Firmus and the Price of AI Infrastructure: Is Australia Ready for an AI Mega-IPO?

October 8, 2026
Firmus’ proposed mega-IPO puts a spotlight on the cost, capital intensity and risks of building AI infrastructure as investors weigh the next phase of the AI boom.

Stock Spotlight: Electro Optic Systems Holdings Ltd (ASX:EOS)

October 6, 2026
About Electro Optic Systems Holdings Ltd. Electro Optic Systems Holdings Limited engages in the development, manufacture, and sale of telescopes and dome enclosures, laser satellite tracking systems, remote weapon systems, and high laser weapon. It operates through Defense Systems and Space Systems segments. The company develops, manufactures, and markets fire control, surveillance, weapon systems, and high energy laser to military customers. It also provides passive optical and laser sensing equipment; optical, microwave and on-the-move radio and satellite products; and laser-based surveillance systems with space tracking capability. In addition, the company offers counter-drone, firepower, force protection, and UGV and marine lethality systems, as well as high energy laser weapon; optical tracking systems, space control, space domain awareness, satellite laser ranging, space sustainability, and precision optics. It operates in Australia, the United States, Singapore, the United Arab Emirates, the United Kingdom, New Zealand, the Netherlands, North America, Germany, and rest of Europe. Electro Optic Systems Holdings Limited was founded in 1983 and is based in Symonston, Australia. Source: EODHD Key Stats

Stock Spotlight: Liontown Ltd (ASX:LTR)

October 6, 2026
About Liontown Ltd. Liontown Limited engages in the exploration, evaluation, and development of mineral properties in Australia. It primarily explores for lithium, gold, and nickel deposits. The company's flagship property is the Kathleen Valley lithium project located in Perth, Western Australia. The company was formerly known as Liontown Resources Limited and change its name to Liontown Limited in November 2025. Liontown Limited was incorporated in 2006 and is headquartered in West Perth, Australia. Source: EODHD Key Stats

The RBA Hikes to 4.60%: A New Inflation Challenge

September 30, 2026
The RBA has raised rates to 4.60% as inflation pressures persist. Explore the impact of energy costs, AI demand and the key signals investors should watch next.

Genomics: Why the Next Wave of Healthcare Innovation Could Be Written in Our DNA

September 22, 2026
Discover how advances in genomics, AI, diagnostics and gene editing are creating a broader healthcare opportunity and where commercial value is emerging.

The AI Trade Just Hit an Uncomfortable Question: What If Progress Slows?

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.